Anixa Biosciences, Inc. (ANIX)
Nasdaq: ANIX · Pharmaceutical Preparations · San Jose, CA · filing with the SEC since 1995
Filings
175 filings since 2017 beside 211 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-K
Annual report for the fiscal year ending Oct 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Jan 29, 2027
10-Q
Quarterly report for the quarter ending Jan 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Mar 17, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Jan 28, 2026.
Filings a yearinsider forms included
3936483620303436
2026 counts to Nov 13, 2026.
SEC letters: 2 in the last 36 months, the newest Sep 26, 2025.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Mar 11, 2026
8-K items 5.07, 7.01, 9.01
Shareholder vote; Investor disclosure (Regulation FD) · Current report
Mar 10, 2026
Mar 21, 2025
8-K items 5.07, 7.01, 9.01
Shareholder vote; Investor disclosure (Regulation FD) · Current report
Mar 20, 2025
May 8, 2024
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
May 3, 2024
Mar 22, 2024
8-K items 5.07, 7.01, 9.01
Shareholder vote; Investor disclosure (Regulation FD) · Current report
Mar 21, 2024
Mar 10, 2023
8-K items 5.07, 7.01, 9.01
Shareholder vote; Investor disclosure (Regulation FD) · Current report
Mar 9, 2023
40 of 175 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.